UNC spinout raises $2M in first private funding round

BioFluidica, a specialty health care company with roots in UNC-Chapel Hill, raised $2 million, closing the company’s first round of private funding. Based on work started by UNC professor Steven A. Soper, BioFluidica is developing a tool to better identify cancer. Because cancers are sometimes not detected until it is too late, scientists hope that next-generation tools to better identify the presence of cancer cells in the bloodstream could lead to earlier and more precise treatment. BioFluidica…